Wu, Sherry Y.
The University of Queensland
4 papers on CoChatORCID 0000-0002-6051-4252
Most cited papers
- Verified
Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer
Kim, H. S., Mendiratta, S., Kim, J., Pecot, C. V., Larsen, J. E., Zubovych, I., Seo, B. Y., Kim, J., Eskiocak, B., Chung, H., et al. (2013) · Cell
Lung Cancer Treatments and MutationsCancer Genomics and Diagnostics
Cited by 172
- Verified
Macrophages facilitate resistance to anti-VEGF therapy by altered VEGFR expression
Dalton, H. J., Pradeep, S., McGuire, M., Hailemichael, Y., MA, S., Lyons, Y., Armaiz-Pena, G. N., Previs, R. A., Hansen, J. M., Rupaimoole, R., et al. (2017) · Clinical Cancer Research
Angiogenesis and VEGF in CancerImmune cells in cancer
Cited by 97
- Verified
PRKCI promotes immune suppression in ovarian cancer
Sarkar, S., Bristow, C. A., Dey, P., Rai, K., Perets, R., Ramirez-Cardenas, A., Malasi, S., Huang-Hobbs, E., Haemmerle, M., Wu, S. Y., et al. (2017) · Genes & Development
Ovarian cancer diagnosis and treatmentHippo pathway signaling and YAP/TAZ
Cited by 93
- Verified
The Advances and Challenges in Utilizing Exosomes for Delivering Cancer Therapeutics
Yang, M., & Wu, S. Y. (2018) · Frontiers in Pharmacology
Extracellular vesicles in diseaseNanoparticle-Based Drug Delivery
Cited by 59
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free